GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence
The present paper summarizes the preclinical and clinical studies conducted to define the anti-alcohol pharmacological profile of the prototypic GABAB receptor agonist, baclofen, and its therapeutic potential for treatment of alcohol use disorder (AUD). Numerous studies have reported baclofen-induce...
Main Authors: | Roberta eAgabio, Giancarlo eColombo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-06-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2014.00140/full |
Similar Items
-
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
by: Roberta Agabio, et al.
Published: (2018-09-01) -
Suppressing Effect of Baclofen on Multiple Alcohol-Related Behaviors in Laboratory Animals
by: Giancarlo Colombo, et al.
Published: (2018-09-01) -
R(+)-baclofen, but not S(-)-baclofen, alters alcohol self-administration in alcohol-preferring rats
by: Irene eLorrai, et al.
Published: (2016-04-01) -
The effect of BLA GABAB receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA
by: Katayoon Kangarlu Haghighi, et al.
Published: (2016-07-01) -
Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice
by: Carla eLobina, et al.
Published: (2011-12-01)